Drug profile · INN
secretin synthetic human
CHIRHOSTIM
secretin synthetic human (CHIRHOSTIM) is a secretin receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — secretin synthetic human
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
secretin synthetic human (CHIRHOSTIM) is a secretin receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Secretin receptor agonist
Primary target: Secretin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is secretin synthetic human?
secretin synthetic human (CHIRHOSTIM) is a secretin receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for secretin synthetic human?
CHIRHOSTIM is a marketed brand name for secretin synthetic human. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of secretin synthetic human?
secretin synthetic human has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.